PL112931B1 - Process for preparing novel 1,5-substituted derivativesof pyrrolidone - Google Patents

Process for preparing novel 1,5-substituted derivativesof pyrrolidone Download PDF

Info

Publication number
PL112931B1
PL112931B1 PL1977215666A PL21566677A PL112931B1 PL 112931 B1 PL112931 B1 PL 112931B1 PL 1977215666 A PL1977215666 A PL 1977215666A PL 21566677 A PL21566677 A PL 21566677A PL 112931 B1 PL112931 B1 PL 112931B1
Authority
PL
Poland
Prior art keywords
pyrrolidone
formula
compounds
ppm
group
Prior art date
Application number
PL1977215666A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL112931B1 publication Critical patent/PL112931B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL1977215666A 1976-08-06 1977-08-08 Process for preparing novel 1,5-substituted derivativesof pyrrolidone PL112931B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (1)

Publication Number Publication Date
PL112931B1 true PL112931B1 (en) 1980-11-29

Family

ID=24861795

Family Applications (2)

Application Number Title Priority Date Filing Date
PL77200124A PL200124A1 (pl) 1976-08-06 1977-08-08 Sposob wytwarzania nowych pochodnych pirolidonu
PL1977215666A PL112931B1 (en) 1976-08-06 1977-08-08 Process for preparing novel 1,5-substituted derivativesof pyrrolidone

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL77200124A PL200124A1 (pl) 1976-08-06 1977-08-08 Sposob wytwarzania nowych pochodnych pirolidonu

Country Status (31)

Country Link
JP (2) JPS5321159A (enExample)
AR (1) AR217080A1 (enExample)
AT (1) AT362887B (enExample)
AU (1) AU508007B2 (enExample)
BE (1) BE857506A (enExample)
BG (1) BG31073A3 (enExample)
CA (1) CA1077948A (enExample)
CH (1) CH624934A5 (enExample)
CS (1) CS221269B2 (enExample)
DD (2) DD143768A5 (enExample)
DE (1) DE2735904A1 (enExample)
DK (1) DK352077A (enExample)
ES (2) ES461388A1 (enExample)
FI (1) FI70009C (enExample)
FR (1) FR2369260A1 (enExample)
GB (2) GB1556570A (enExample)
GR (1) GR68688B (enExample)
HU (1) HU180273B (enExample)
IE (1) IE45505B1 (enExample)
IL (1) IL52615A (enExample)
LU (1) LU77936A1 (enExample)
NL (1) NL7708637A (enExample)
NO (1) NO772752L (enExample)
NZ (1) NZ184806A (enExample)
PH (1) PH17398A (enExample)
PL (2) PL200124A1 (enExample)
PT (1) PT66891B (enExample)
SE (1) SE423813B (enExample)
SU (3) SU703016A3 (enExample)
YU (1) YU192577A (enExample)
ZA (1) ZA774704B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
ATE327751T1 (de) * 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
WO2002024647A1 (en) * 2000-09-21 2002-03-28 Ono Pharmaceutical Co., Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
NZ525164A (en) * 2000-11-27 2005-04-29 Pfizer Prod Inc EP4 receptor selective agonists in the treatment of osteoporosis
RU2303451C2 (ru) * 2001-07-23 2007-07-27 Оно Фармасьютикал Ко., Лтд. Фармацевтические композиции для лечения заболеваний, связанных с уменьшением костной массы, включающие агонист ер4 в качестве активного ингредиента
MXPA04005555A (es) * 2002-03-18 2005-05-16 Pfizer Prod Inc Procedimientos de tratamiento con agonistas selectivos del receptor ep4.
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
EP1586564B1 (en) * 2003-01-21 2012-11-28 Ono Pharmaceutical Co., Ltd. 8-azaprostaglandin derivatives and medicinal uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (ja) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22piroridonjudotaino seiho
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (de) * 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
IL52615A (en) 1981-09-13
NO772752L (no) 1978-02-07
CS221269B2 (en) 1983-04-29
SE7708642L (sv) 1978-02-07
YU192577A (en) 1983-04-30
LU77936A1 (enExample) 1978-04-27
FI70009B (fi) 1986-01-31
PH17398A (en) 1984-08-08
GB1556570A (en) 1979-11-28
DE2735904A1 (de) 1978-02-09
JPS5555161A (en) 1980-04-22
SU818480A3 (ru) 1981-03-30
IE45505L (en) 1978-02-06
NL7708637A (nl) 1978-02-08
JPS5531147B2 (enExample) 1980-08-15
ZA774704B (en) 1978-06-28
BG31073A3 (bg) 1981-10-15
AT362887B (de) 1981-06-25
AR217080A1 (es) 1980-02-29
JPS5321159A (en) 1978-02-27
FR2369260B1 (enExample) 1982-02-12
ES461388A1 (es) 1978-12-01
FI772376A7 (enExample) 1978-02-07
NZ184806A (en) 1980-04-28
AU2751577A (en) 1979-02-08
DD136135A5 (de) 1979-06-20
FR2369260A1 (fr) 1978-05-26
SU703016A3 (ru) 1979-12-05
IE45505B1 (en) 1982-09-08
PT66891A (en) 1977-09-01
BE857506A (fr) 1978-02-06
CA1077948A (en) 1980-05-20
FI70009C (fi) 1986-09-12
HU180273B (en) 1983-02-28
GR68688B (enExample) 1982-02-01
ATA579477A (de) 1980-11-15
CH624934A5 (enExample) 1981-08-31
PL200124A1 (pl) 1978-05-22
SE423813B (sv) 1982-06-07
IL52615A0 (en) 1977-10-31
PT66891B (en) 1979-01-26
ES471349A1 (es) 1979-09-16
JPS585196B2 (ja) 1983-01-29
AU508007B2 (en) 1980-03-06
DK352077A (da) 1978-02-07
SU850000A3 (ru) 1981-07-23
DD143768A5 (de) 1980-09-10
GB1556569A (en) 1979-11-28

Similar Documents

Publication Publication Date Title
RU2707067C2 (ru) Полициклические соединения и способы их применения
DE69922703T2 (de) Ureido-thiobuttersäurederivate als ppar-agonisten
JPH05310664A (ja) ビアリール置換4−アミノ酪酸アミド
FR2698873A1 (fr) Benzocycloheptènes, benzoxépines et benzothiépines activateurs des canaux potassiques, procédé de préparation, composition pharmaceutique les contenant.
CA1161447A (en) 8-aza-16,16-difluoroprostanoids
KR100635955B1 (ko) 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제
PL112931B1 (en) Process for preparing novel 1,5-substituted derivativesof pyrrolidone
NO147836B (no) Nye 16-aryloksy-substituerte omega-tetranorprostaglandiner for anvendelse som fruktbarhetsregulerende middel, svangerskapsavbrytende middel eller middel for synkronisering av brunstcyklusen hos husdyr
Tomiyama et al. Synthesis and biological activity of novel carbacyclins having bicyclic substituents on the. omega.-chain
US4619938A (en) Fatty acid derivatives of aminoalkyl nicotinic acid esters and platelet aggregation inhibitors
MC1498A1 (fr) Procede de preparation de composes pyridyliques ayant une activite antihistaminique
DD206376A5 (de) Verfahren zur herstellung von benzofuranonen
DE69918433T2 (de) C11-oxymyl- and hydroxylamino-prostaglandine und ihre anwendung als arzneimittel
US20030083375A1 (en) 11Beta-fluoro 15beta-hydroxy PGF2alpha analogs as FP receptor antagonists
JPH04247082A (ja) 新スピロ〔4.5〕デカン化合物および医薬品組成物
DE2737808A1 (de) 2-substituierte aryl-heterocyclische omega-pentanorprostaglandine
FR2821356A1 (fr) Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
CA2533432C (fr) Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
KR100633349B1 (ko) 아미노산 유도체 및 이들을 유효 성분으로서 함유하는 약제
CA1152505A (en) Prostaglandin derivatives in the 6-keto-pge.sub.1 series
MC1562A1 (fr) Phenothiazines,leur procede de preparation et produits en contenant
Ohata et al. Synthesis and Biological Activity of Enantiomeric Pairs of 5-(Alk-2-enyl) thiolactomycin and 5-[(E)-Cycloalk-2-enylidenemethyl] thiolactomycin Congeners
KR840000964B1 (ko) 15-설폰아미도프로스타글란딘 유도체의 제조방법
EP0012801A1 (de) 2-(1-Phenyl-2,5-cyclohexadienyl)-äthylaminderivate, Verfahren zu deren Herstellung, deren Verwendung als pharmazeutische Wirkstoffe sowie diese enthaltende Arzneimittel
DK154214B (da) Analogifremgangsmaade til fremstilling af 2-oxabicyclo-(3,3,0)octanderivater